NCT01128738View on ClinicalTrials.gov

GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis

PHASE3CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Hyperhidrosis
Interventions
DRUG

GSK1358820

Onabotulinum toxin type A

DRUG

Placebo

Placebo

Trial Locations (14)

480-1195

GSK Investigational Site, Aichi

220-6208

GSK Investigational Site, Kanagawa

983-0039

GSK Investigational Site, Miyagi

330-0854

GSK Investigational Site, Saitama

107-0052

GSK Investigational Site, Tokyo

113-8519

GSK Investigational Site, Tokyo

141-8625

GSK Investigational Site, Tokyo

158-0094

GSK Investigational Site, Tokyo

158-0097

GSK Investigational Site, Tokyo

165-0026

GSK Investigational Site, Tokyo

166-0003

GSK Investigational Site, Tokyo

174-0071

GSK Investigational Site, Tokyo

178-0063

GSK Investigational Site, Tokyo

182-0002

GSK Investigational Site, Tokyo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01128738 - GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis | Biotech Hunter | Biotech Hunter